Blue Horseshoe Stocks: VTVT Recap & More

vTv Therapeutics, Inc. VTVT

Our report yesterday morning included  a look at the VTVT chart, and establishing our interest in tracking it as a bottom play. Our timing in this really could not have been any better as the stock not only made it biggest single session move of the year, but also traded its highest volume.

VTVT ran from a low of .79 and reached as high as 1.67, a 53% intraday rip, and ended up closing at 1.19, filling a portion of the large gap which you can plainly see below. Based on the activity we’ve now witnessed, and the still-ripe look of the chart, we’re going to continue to keep a close watch over VTVT.


Van Eck Vectors Gold Miners ETF (GDX)

We also want to begin tracking a pair of options contracts in the GDX chain. Gold has been doing well and looks as if another solid day could be in the cards.

On that event, there should be some nice activity in the GDX Weekly $22.50 & $23 Calls, so we’ll be monitoring for that.



Tandem Diabetes Care, Inc. TNDM – Update

It was a week ago today that we were commenting on our coverage of TNDM in 2018. We caught this stock at a low of 2.14 earlier this year, and it has come a long way since then.

This week the stock has traded up to a high of 7.75, marking an increase of 262% since we began tracking it.


Extended Watchlist:
TEUM, ARQL, SPWR, PRPO, INPX, USLV, OAS

Comments are closed.